论文部分内容阅读
经胃镜确诊９０例消化性溃疡（Ｐｕ）活动期，按２：１设胃溃灵组６０例，雷尼替丁组３０例。经治疗６周后．两组的胃镜疗效及胃痛疗效相似，胃溃灵的１年复发率为２０％，而雷尼替丁的１年复发率为５０％，胃溃灵的远期疗效明显优于雷尼替丁（Ｐ＜０．０１），并随机对胃溃灵组２１例患者进行临床实验研究，发现胃溃灵具有抑制十二指肠溃疡（Ｄｕ）的基础胃酸（ＢＡＯ），降低Ｄｕ的胃蛋白酶（ＰＡ）活性，促进Ｐｕ胃粘膜合成分泌前列腺素Ｅ２（ＰＧＥ２），补充锌元素，有保护胃粘膜屏障的作用。
Gastroscopy diagnosed 90 cases of peptic ulcer (Pu) active phase, according to 2: 1 set up gastric ulceration group 60 cases, ranitidine group 30 cases. After 6 weeks of treatment. Gastroscopy curative effect and gastric pain were similar between the two groups. The one-year recurrence rate of gastric ulcer was 20%, while the one-year relapse rate of ranitidine was 50%. The long-term curative effect of gastric ulcer was superior to that of ranitidine (P <0.01), and randomized to 21 cases of gastric ulcer group clinical experimental study found that stomach ulcer with inhibitory duodenal ulcer (Du) basic gastric acid (BAO), reduce Du pepsin ( PA) activity, and promote Pu gastric mucosal synthesis and secretion of prostaglandin E2 (PGE2), zinc supplements, the role of protecting the gastric mucosal barrier.